MedKoo Cat#: 531846 | Name: Gea 3162

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Gea 3162 is a potent inhibitor of ADP-induced platelet aggregation in platelet rich plasma (PRP). GEA 3162 stimulates cGMP production in platelets, granulocytes, and polymorphonuclear leukocytes.

Chemical Structure

Gea 3162
Gea 3162
CAS#144576-10-3

Theoretical Analysis

MedKoo Cat#: 531846

Name: Gea 3162

CAS#: 144576-10-3

Chemical Formula: C7H6Cl2N4O

Exact Mass: 231.9919

Molecular Weight: 233.05

Elemental Analysis: C, 36.08; H, 2.60; Cl, 30.42; N, 24.04; O, 6.86

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Gea 3162; Gea3162; Gea-3162.
IUPAC/Chemical Name
1,2,3,4-Oxatriazolium, 5-amino-3-(3,4-dichlorophenyl)-, inner salt
InChi Key
LNALNDHRNONVMD-UHFFFAOYSA-N
InChi Code
InChI=1S/C7H6Cl2N4O/c8-5-2-1-4(3-6(5)9)13-11-7(10)14-12-13/h1-3,13H,(H2,10,11)
SMILES Code
ClC1=CC=C([NH+]2[N-]OC(N)=N2)C=C1Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 233.05 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Corell, T., et al., . Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Polish journal of pharmacology. 46(6): 553-66. PMID: 7542520 2. Karup, G., et al., . Mesoionic oxatriazole derivatives--a new group of NO-donors. Polish journal of pharmacology. 46(6): 541-52. PMID: 7620516